NetworkNewsBreaks – Pressure BioSciences Inc.’
Post# of 1354
(Total Views: 284)
Posted On: 03/20/2020 4:15:38 PM
NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST Demonstration Laboratory Showcases Groundbreaking Technology
Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://nnw.fm/5Ic0n). An article discussing the company reads, “The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (‘CBD’) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast majority of CBD products today. . . . The second objective is to invite potential purchasers of the company’s BaroShear nanoemulsification system to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. The company expects to install and invoice the initial 12 BaroShear K45 systems in the fourth quarter of 2020.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://nnw.fm/5Ic0n). An article discussing the company reads, “The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (‘CBD’) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast majority of CBD products today. . . . The second objective is to invite potential purchasers of the company’s BaroShear nanoemulsification system to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. The company expects to install and invoice the initial 12 BaroShear K45 systems in the fourth quarter of 2020.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼